Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability.
about
Clinical Implications of Glucose Variability: Chronic Complications of DiabetesEvaluation of an open access software for calculating glucose variability parameters of a continuous glucose monitoring system applied at pediatric intensive care unit.Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data.Outpatient glycemic control with a bionic pancreas in type 1 diabetes.Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring.Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies.Glycemic Profiles of Healthy Individuals with Low Fasting Plasma Glucose and HbA1c.Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemiaInsulin degludec requires lower bolus insulin doses than does insulin glargine in Japanese diabetic patients with insulin-dependent state.A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China.Are glucose levels, glucose variability and autonomic control influenced by inspiratory muscle exercise in patients with type 2 diabetes? Study protocol for a randomized controlled trial.Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.Glycemic variability in relation to oral disposition index in the subjects with different stages of glucose tolerance.Clinical impact of sample interference on intensive insulin therapy in severely burned patients: a pilot studyDynamic Stress Factor (DySF): A Significant Predictor of Severe Hypoglycemic Events in Children with Type 1 DiabetesGlycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?A comparison of two insulin infusion protocols in the medical intensive care unit by continuous glucose monitoring.Blue flash ERG PhNR changes associated with poor long-term glycemic control in adolescents with type 1 diabetes.Factors influencing inter-day glycemic variability in diabetic outpatients receiving insulin therapy.Use of a glucose management service improves glycemic control following vascular surgery: an interrupted time-series study.Associations of blood glucose dynamics with antihyperglycemic treatment and glycemic variability in type 1 and type 2 diabetes.Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.Glycemic variability: Clinical implications.Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes.Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.Glycemic Variability and Its Association With Demographics and Lifestyles in a General Adult Population.Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: a Graphical User Interface for Diabetes Evaluation (CGM-GUIDE©).Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM).High Liver Enzyme Concentrations are Associated with Higher Glycemia, but not with Glycemic Variability, in Individuals without Diabetes Mellitus.Adding of Sitagliptin on Insulin Therapy Effectively and Safely Reduces a Hemoglobin A1c Level and Glucose Fluctuation in Japanese Patients with Type 2 Diabetes.Computing the risk of postprandial hypo- and hyperglycemia in type 1 diabetes mellitus considering intrapatient variability and other sources of uncertainty.Lack of advantage of high-fibre, moderate-carbohydrate diets in dogs with stabilised diabetes.Characterizing maternal glycemic control: a more informative approach using semiparametric regression.Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus.[Comparative study among five different treatments on the clinical and laboratory changes in rats with alloxan-induced diabetes].Aspiration of the subcutaneous insulin injection: clinical evaluation of needle size and amount of subcutaneous fat.Use of telemedicine in subjects with type 1 diabetes equipped with an insulin pump and real-time continuous glucose monitoring.The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus.
P2860
Q26801671-123EDA28-22E4-41F5-A97C-BF17895AB0F5Q30487867-EF8910BE-2173-41C2-8D7D-ED469173897DQ33466598-1D0DB436-3657-4B03-93B7-861ECC5E48B4Q33884211-E0AA7D1F-F2B0-42A6-934A-222A002AB8A3Q34283269-8074B8DE-DD67-41EF-9DA7-BEA4AFF026DFQ35115119-04D62212-BE8E-4EB4-BC1A-CFF836565FFBQ35177261-B5187C21-6090-4477-B5FE-CA0232E57CE3Q35619522-383BF2B5-C2B4-47D0-8F13-A43E6C42A025Q35684670-993B6FE9-BB62-42A3-98ED-3A7C76586FC8Q35751626-69233850-7D23-4D24-944C-164D5F219B95Q36158944-8AB468A1-E7F9-4801-AB57-3FACEA8A6EEAQ36434390-F713FB13-BA80-4ABA-8692-8DC0814B1890Q36481669-082AEF93-8171-4B43-A2F3-67366582F3ADQ36705282-F8F5FAE8-1AE1-466C-849A-4C3260B7C6CDQ37056930-53779CD4-B660-413D-88CC-45F62BBACDA8Q37273782-277192A0-8DB0-4804-AEB1-08FF8695AB86Q37384180-8220C113-C599-4E41-B2AE-662F393DB549Q37404282-3087C572-260C-4DCE-B6D6-7AA93797AD89Q37430563-4CF8BE34-1AF6-40ED-9976-481BEBECFEF2Q37431719-F61F56D9-B449-485A-8E63-2653D6FC9A5BQ37567669-26E990EA-03F1-4A5E-8511-6962348345B9Q37625083-5E4301B5-083A-440E-A021-9F05ECCC43B1Q38796605-A12EC9E0-223B-4411-B671-6ED23FE2CDB5Q39071115-06EB1E2A-3969-40B6-BF5D-450E4AD2EA10Q39364360-84B773EC-9EBC-42E8-811F-479CF28B4CDDQ39692509-F4902B96-1079-4458-B628-320C628B5BACQ40258044-15C8F3DD-7E43-4E5F-8B39-AAA71E956696Q40285901-C8A296A6-1530-411B-8E5C-81299A616840Q40571655-23BB1676-FDC1-413A-9DD2-6EF19EE9F3C8Q41259386-6FE62A57-6EE7-4DC8-981E-1BCF3E031456Q41684025-B45163D6-29C2-4721-9588-15471F32396EQ42010765-EDA17C4A-4639-41F4-BF7D-3F0980B0A170Q42599701-6488A438-F981-48BB-9633-14DFCEDC458CQ43265065-95AF17BC-4897-471D-A98A-512725668983Q43518606-1BAE461F-F09A-49E6-BF79-76DCAE2AC546Q46133537-2DB6DE4A-645C-4582-B797-199700677C4CQ46422018-A474E090-8C97-4B9F-874E-965FCAF86ED4Q47351360-4FFFB387-F6FB-4102-91FB-372774D08EA6Q48398157-04125399-1C89-4DC8-8BEB-715A8854A6B1Q50886790-B0877BEF-F808-4FD3-9D88-A38488767FB6
P2860
Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
Day-to-day variation of contin ...... asure of diabetic instability.
@en
Day-to-day variation of contin ...... asure of diabetic instability.
@nl
type
label
Day-to-day variation of contin ...... asure of diabetic instability.
@en
Day-to-day variation of contin ...... asure of diabetic instability.
@nl
prefLabel
Day-to-day variation of contin ...... asure of diabetic instability.
@en
Day-to-day variation of contin ...... asure of diabetic instability.
@nl
P2093
P356
P1433
P1476
Day-to-day variation of contin ...... asure of diabetic instability.
@en
P2093
P2888
P304
P356
10.1007/BF01218495
P577
1972-11-01T00:00:00Z